ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; clotrimazole; gentamicin (as sulfate) - קרם - clotrimazole 10 mg/g; betamethasone as dipropionate 0.5 mg/g; gentamicin (as sulfate) 1 mg/g - corticosteroids, potent, other combinations - treatment of corticosteroid-responsive dermatoses when complicated by infections caused by bacteria (sensitive to gentamicin) and fungi (sensitive to clotrimazole) or when the possibility of such infections is suspected. the cream is suitable for the use of oozing eczema.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; salicylic acid - תרחיץ - salicylic acid 20 mg/g; betamethasone as dipropionate 0.5 mg/g - corticosteroids, potent, other combinations - provides anti-inflammatory, antipruritic, anti-allergic and keratinolytic activity in the topical management of subacute and chronic hyperkeratotic and dry dermatoses responsive to corticosteroid therapy

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - betamethasone dipropionate; clotrimazole - קרם - clotrimazole 1 %w/w; betamethasone dipropionate 0.064 %w/w - betamethasone - betamethasone - clotrimazole and betamethasone dipropionate cream, are indicated for the topical treatment of the following dermal infections: tinea pedis, tinea cruris, and tinea corporis due to trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosusm.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - betamethasone as dipropionate; salicylic acid - משחה - salicylic acid 30 mg/g; betamethasone as dipropionate 0.5 mg/g - betamethasone - betamethasone - provides anti inflammatory, antipruritic, anti allergic and chronic hyperkeratotic and dry keratolytic activity in the topical management of subacute dermatoses responsive to corticosteroid therapy.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - caffeine; paracetamol - קפליות - paracetamol 500 mg; caffeine 50 mg - paracetamol, combinations excl. psycholeptics - paracetamol, combinations excl. psycholeptics - relief of pain and fever of different etiologies such as headache, toothache, colds, influenza, rheumatic pain and dysmenorrhea.

ישראל - עברית - Ministry of Health

פריגו ישראל סוכנויות בע"מ-טאיקו דיאגנוסטיקה - רופא - מערכת לניטור רציף של רמת הסוכר בדם

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 250 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 500 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 750 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - levetiracetam - טבליה - levetiracetam 1000 mg - levetiracetam - levetiracetam - levetiracetam dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.levetiracetam dexcel is indicated as adjunctive therapy:• in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy.• in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.